Prognostic Factors for Survival in Adult Patients with Recurrent Glioma Enrolled on New Approaches to Brain Tumor Therapy “NABTT” CNS Consortium Phase I and II Clinical Trials

von Carson, Kathryn A., Grossman, Stuart A., Fisher, Joy D., Shaw, Edward G.
Veröffentlicht 2007

Phase II Clinical and Pharmacologic Study of Radiation Therapy and Carboxyamido-triazole (CAI) in Adults with Newly Diagnosed Glioblastoma Multiforme(1)

von Mikkelsen, Tom, Lush, Richard, Grossman, Stuart A., Carson, Kathryn A., Fisher, Joy D., Alavi, Jane B., Rosenfeld, Steve
Veröffentlicht 2006

Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma

von Phuphanich, Surasak, Carson, Kathryn A., Grossman, Stuart A., Lesser, Glenn, Olson, Jeffrey, Mikkelsen, Tom, Desideri, Serena, Fisher, Joy D.
Veröffentlicht 2008

Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma,

von Brem, Steven, Grossman, Stuart A., Carson, Kathryn A., New, Pamela, Phuphanich, Surasak, Alavi, Jane B., Mikkelsen, Tom, Fisher, Joy D.
Veröffentlicht 2005

Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: A dose escalation and pharmacologic study

von Phuphanich, Surasak, Baker, Sharyn D., Grossman, Stuart A., Carson, Kathryn A., Gilbert, Mark R., Fisher, Joy D., Carducci, Michael A.
Veröffentlicht 2005

Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas

von Rudek, Michelle A., New, Pamela, Mikkelsen, Tom, Phuphanich, Surasak, Alavi, Jane B., Nabors, Louis B., Piantadosi, Steven, Fisher, Joy D., Grossman, Stuart A.
Veröffentlicht 2011

Phase I Trial of Polifeprosan 20 With Carmustine Implant Plus Continuous Infusion of Intravenous O(6)-Benzylguanine in Adults With Recurrent Malignant Glioma: New Approaches to Bra...

von Weingart, Jon, Grossman, Stuart A., Carson, Kathryn A., Fisher, Joy D., Delaney, Shannon M., Rosenblum, Mark L., Olivi, Alessandro, Judy, Kevin, Tatter, Stephen B., Dolan, M. Eileen
Veröffentlicht 2007

A Safety Run-in and Randomized Phase II Study of Cilengitide Combined with Chemoradiation for Newly Diagnosed Glioblastoma (NABTT 0306)

von Nabors, L. Burt, Mikkelsen, Tom, Hegi, Monika E., Ye, Xiaubu, Batchelor, Tracy, Lesser, Glenn, Peereboom, David, Rosenfeld, Myrna R., Olsen, Jeff, Brem, Steve, Fisher, Joy D., Grossman, Stuart A.
Veröffentlicht 2012

A Phase I and Correlative Biology Study of Cilengitide in Patients with Recurrent Malignant Glioma

von Nabors, L. Burt, Mikkelsen, Tom, Rosenfeld, Steve, Hochberg, Fred, Akella, N. Shastry, Fisher, Joy D., Cloud, Gretchen, Zhang, Yu, Carson, Kathryn A., Wittemer, Sabine M., Colevas, A. Dimitrios, Grossman, Stuart A.
Veröffentlicht 2007

NIMG-35 RESULTS OF EXPLORATORY 18F-FLT PET IMAGING IN TEN RECURRENT HIGH-GRADE GLIOMA PATIENTS TREATED WITH THE SELECTIVE T-TYPE CALCIUM CHANNEL BLOCKER MIBEFRADIL FOLLOWED BY TEMO...

von Holdhoff, Matthias, Lodge, Martin A., Bag, Asim K., Nabors, L. Burt, Mintz, Akiva, Lesser, Glenn J., Mankoff, David A., Desai, Arati S., Lieberman, Frank S., Leal, Jeffrey, Fisher, Joy D., Desideri, Serena, Ye, Xiaobu, Grossman, Stuart A., Schiff, David, Wahl, Richard L.
Veröffentlicht in Neuro Oncol (2015)

Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas

von Holdhoff, Matthias, Ye, Xiaobu, Supko, Jeffrey G., Nabors, Louis B., Desai, Arati S., Walbert, Tobias, Lesser, Glenn J., Read, William L., Lieberman, Frank S., Lodge, Martin A., Leal, Jeffrey, Fisher, Joy D., Desideri, Serena, Grossman, Stuart A., Wahl, Richard L., Schiff, David
Veröffentlicht in Neuro Oncol (2017)

Repeatability of (18)F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma

von Lodge, Martin A., Holdhoff, Matthias, Leal, Jeffrey P., Bag, Asim K., Nabors, L. Burt, Mintz, Akiva, Lesser, Glenn J., Mankoff, David A., Desai, Arati S., Mountz, James M., Lieberman, Frank S., Fisher, Joy D., Desideri, Serena, Ye, Xiaobu, Grossman, Stuart A., Schiff, David, Wahl, Richard L.
Veröffentlicht in J Nucl Med (2017)